Inhibition of corticotrophin releasing factor secretion in the pentobarbitone-morphine-treated rat

1984 ◽  
Vol 98 (2) ◽  
pp. 211-221 ◽  
Author(s):  
Julia C. Buckingham
1983 ◽  
Vol 97 (3) ◽  
pp. 339-346 ◽  
Author(s):  
U. Beckford ◽  
M. C. Holmes ◽  
B. Gillham ◽  
M. T. Jones

The effect of various steroids on the functional activity of the rat hypothalamus in vitro was investigated. The addition of corticosterone (10−7 mol/l) for 30 min to the incubation medium inhibited immediately the release of bioactive corticotrophin releasing factor (CRF) by tissue induced by serotonin (2·6×10−8 mol/l). This was followed by a period lasting from 30 min (coincident with removal of the steroid from the medium) to 60 min when no inhibition was seen. Finally a second period of suppression of hypothalamic CRF activity in vitro was shown to be fully established 120 min after addition of the steroid. In more detailed investigations the latter inhibition was shown to occur when the tissue was exposed to the steroid (3×10−7 mol/l) for 5 or 30 min, but not for 1 min, and it was dose-related. Of other steroids investigated, progesterone in high concentrations (3 × 10−6 mol/l) suppressed to a small extent the functional activity of the hypothalamus in vitro but 17α-hydroxyprogesterone, 11α-hydroxyprogesterone, 11α,17α-dihydroxyprogesterone and 11-epicortisol had no effect on the delayed inhibition. Progesterone (10−7 mol/l) potentiated the ability of corticosterone (10−8 mol/l) to induce the delayed suppression of hypothalamic CRF activity in vitro. In contrast, 17α-hydroxyprogesterone, 11α-hydroxyprogesterone, 1 1α,17α-dihydroxyprogesterone and 11-epicortisol competitively antagonized this inhibitory action of corticosterone (3 × 10−7 mol/l) in a dose-related manner (1·5 × 10−8–3 × 10−8 mol/l). The action of the antagonist 11-epicortisol was similar whether it was added to the tissue in vitro before corticosterone or antagonist and agonist were added together. The functional characterization of steroid action on the hypothalamus may lead to a clearer understanding of the mechanism by which the compounds influence hormone release.


2004 ◽  
Vol 171 (4S) ◽  
pp. 453-454 ◽  
Author(s):  
Adam P. Klausner ◽  
Tomi Streng ◽  
Jerry Raju ◽  
Jeremy B. Tuttle ◽  
Karl-Erik Andersson ◽  
...  

Genetics ◽  
1999 ◽  
Vol 153 (2) ◽  
pp. 753-762
Author(s):  
Günther E Roth ◽  
Sigrid Wattler ◽  
Hartmut Bornschein ◽  
Michael Lehmann ◽  
Günter Korge

Abstract The Drosophila melanogaster gene Sgs-1 belongs to the secretion protein genes, which are coordinately expressed in salivary glands of third instar larvae. Earlier analysis had implied that Sgs-1 is located at the 25B2-3 puff. We cloned Sgs-1 from a YAC covering 25B2-3. Despite using a variety of vectors and Escherichia coli strains, subcloning from the YAC led to deletions within the Sgs-1 coding region. Analysis of clonable and unclonable sequences revealed that Sgs-1 mainly consists of 48-bp tandem repeats encoding a threonine-rich protein. The Sgs-1 inserts from single λ clones are heterogeneous in length, indicating that repeats are eliminated. By analyzing the expression of Sgs-1/lacZ fusions in transgenic flies, cis-regulatory elements of Sgs-1 were mapped to lie within 1 kb upstream of the transcriptional start site. Band shift assays revealed binding sites for the transcription factor fork head (FKH) and the factor secretion enhancer binding protein 3 (SEBP3) at positions that are functionally relevant. FKH and SEBP3 have been shown previously to be involved in the regulation of Sgs-3 and Sgs-4. Comparison of the levels of steady state RNA and of the transcription rates for Sgs-1 and Sgs-1/lacZ reporter genes indicates that Sgs-1 RNA is 100-fold more stable than Sgs-1/lacZ RNA. This has implications for the model of how Sgs transcripts accumulate in late third instar larvae.


Sign in / Sign up

Export Citation Format

Share Document